Marathon Mission Inc. Acquires New Shares in Lam Research Corporation $LRCX

Marathon Mission Inc. bought a new position in Lam Research Corporation (NASDAQ:LRCX) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 3,694 shares of the semiconductor company’s stock, valued at approximately $495,000.

Several other hedge funds and other institutional investors have also bought and sold shares of LRCX. Vanguard Group Inc. raised its holdings in shares of Lam Research by 1.1% during the second quarter. Vanguard Group Inc. now owns 130,609,265 shares of the semiconductor company’s stock valued at $12,713,506,000 after purchasing an additional 1,457,163 shares during the last quarter. State Street Corp grew its position in Lam Research by 1.1% in the 2nd quarter. State Street Corp now owns 59,551,547 shares of the semiconductor company’s stock worth $5,810,172,000 after purchasing an additional 629,666 shares during the period. JPMorgan Chase & Co. grew its position in Lam Research by 14.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock worth $3,954,188,000 after purchasing an additional 5,102,589 shares during the period. Geode Capital Management LLC raised its stake in Lam Research by 3.5% during the 2nd quarter. Geode Capital Management LLC now owns 33,802,736 shares of the semiconductor company’s stock valued at $3,280,484,000 after buying an additional 1,135,405 shares during the last quarter. Finally, Norges Bank bought a new position in shares of Lam Research during the 2nd quarter valued at $1,894,585,000. Institutional investors own 84.61% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on LRCX shares. Morgan Stanley upped their price objective on Lam Research from $137.00 to $158.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 2nd. Mizuho boosted their price target on Lam Research from $170.00 to $200.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. Sanford C. Bernstein increased their price objective on shares of Lam Research from $170.00 to $175.00 and gave the stock an “outperform” rating in a research note on Friday, November 21st. Barclays set a $142.00 target price on shares of Lam Research and gave the company an “equal weight” rating in a research report on Monday, October 20th. Finally, Berenberg Bank increased their price target on shares of Lam Research from $122.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Twenty-six research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $161.21.

Insiders Place Their Bets

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the transaction, the director directly owned 1,652 shares in the company, valued at $264,303.48. This represents a 44.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the sale, the chief financial officer owned 987,237 shares in the company, valued at approximately $148,677,892.20. The trade was a 3.90% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is currently owned by insiders.

Lam Research Price Performance

NASDAQ LRCX opened at $177.24 on Friday. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $177.56. The stock has a market cap of $222.62 billion, a price-to-earnings ratio of 39.04, a PEG ratio of 2.05 and a beta of 1.77. The company’s 50 day moving average is $157.66 and its two-hundred day moving average is $125.34.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company’s revenue for the quarter was up 27.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s payout ratio is presently 22.91%.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: AI-driven equipment demand is being cited as the main catalyst — recent reports say strong AI-related wafer fab orders lifted margins and the company narrative, supporting a multi-quarter revenue/earnings upgrade for Lam. Lam Research (LRCX) Is Up 7.4% After AI-Driven Equipment Demand Lifts Margins And Outlook Narrative
• Positive Sentiment: Analyst momentum and institutional research support (including a maintained buy from UBS) have helped lift sentiment and trading activity, contributing to intraday strength. UBS maintains Lam Research (LRCX) buy recommendation
• Positive Sentiment: Options volume and momentum signals spiked alongside analyst upgrades, amplifying short-term upside and helping push the stock to a new 52‑week high. Lam Research Target of Unusually High Options Trading (NASDAQ:LRCX)
• Positive Sentiment: Multiple outlets are upgrading the long-term growth thesis — coverage highlights secular AI tailwinds, attractive margins and valuation re-rating potential as reasons to stay long-term bullish. Lam Research (LRCX): Assessing Valuation After AI-Driven Upgrades and Strong Wafer Fab Demand
• Neutral Sentiment: Reported short-interest data for late December appears unreliable/zero in the feeds; nothing actionable from these figures for now, so short-squeeze risk is unclear.
• Negative Sentiment: Delphi Management trimmed its stake (sold 4,149 shares, ~24.9% of its holding), a small institutional sell that could be viewed as a minor negative signal but is unlikely to alter the broader market view given the size. Delphi Management Inc. MA Sells 4,149 Shares of Lam Research Corporation $LRCX

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.